National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 1,440 shares of the business’s stock in a transaction dated Wednesday, September 21st. The shares were sold at an average price of $16.01, for a total value of $23,054.40. Following the completion of the transaction, the chief executive officer now directly owns 6,467,744 shares in the company, valued at $103,548,581.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of National Research Corp. (NASDAQ:NRCIB) traded up 1.6323% on Wednesday, hitting $36.1811. The stock had a trading volume of 236 shares. The firm has a 50 day moving average of $33.92 and a 200-day moving average of $35.16. National Research Corp. has a 1-year low of $31.36 and a 1-year high of $44.60. The firm has a market capitalization of $876.34 million, a price-to-earnings ratio of 44.4485 and a beta of 0.28.

National Research Corp. (NASDAQ:NRCIB) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.18. National Research Corp. had a return on equity of 33.74% and a net margin of 18.75%. Equities analysts predict that National Research Corp. will post $0.82 earnings per share for the current year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

The company also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, September 28th. This represents a $1.92 dividend on an annualized basis and a yield of 5.31%. National Research Corp.’s payout ratio is 408.52%.

A hedge fund recently bought a new stake in National Research Corp. stock. WCM Investment Management CA purchased a new position in shares of National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,808 shares of the company’s stock, valued at approximately $1,554,000. WCM Investment Management CA owned 0.19% of National Research Corp. as of its most recent filing with the SEC. 2.90% of the stock is owned by hedge funds and other institutional investors.

Separately, Zacks Investment Research raised National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research note on Friday, August 12th.

About National Research Corp.

National Research Corp. is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.